Resistance patterns to anti-PD-1 therapy in metastatic melanoma

Chin Clin Oncol. 2016 Dec;5(6):75. doi: 10.21037/cco.2016.08.01. Epub 2016 Aug 22.

Authors

Alpaslan Ozgun¹, Vernon K Sondak¹, Joseph Markowitz²

Affiliations

¹ Department of Cutaneous Oncology, Moffitt Cancer Center, and Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
² Department of Cutaneous Oncology, Moffitt Cancer Center, and Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA. [email protected].

No abstract available

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Humans
Melanoma / pathology
Melanoma / therapy*
Neoplasm Metastasis
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
Skin Neoplasms / pathology
Skin Neoplasms / therapy*

Substances

Antibodies, Monoclonal
PDCD1 protein, human
Programmed Cell Death 1 Receptor

Grants and funding